KEGG   DRUG: Landogrozumab
Entry
D11235                      Drug                                   
Name
Landogrozumab (USAN/INN)
Formula
C6338H9790N1694O1988S42
Exact mass
142784.5317
Mol weight
142872.51
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGLTFS RYPMSWVRQA PGKGLVWVSA ITSSGGSTYY
SDTVKGRFTI SRDNAKNTLY LQMNSLRAED TAVYYCARLP DYWGQGTLVT VSSASTKGPS
VFPLAPCSRS TSESTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS
VVTVPSSSLG TKTYTCNVDH KPSNTKVDKR VESKYGPPCP PCPAPEFLGG PSVFLFPPKP
KDTLMISRTP EVTCVVVDVS QEDPEVQFNW YVDGVEVHNA KTKPREEQFN STYRVVSVLT
VLHQDWLNGK EYKCKVSNKG LPSSIEKTIS KAKGQPREPQ VYTLPPSQEE MTKNQVSLTC
LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SRLTVDKSRW QEGNVFSCSV
MHEALHNHYT QKSLSLSLG
(Light chain)
EIVLTQSPGT LSLSPGERAT LSCRASSSVS SSYLHWYQQK PGQAPRLLIY STSNLVAGIP
DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ HHSGYHFTFG GGTKVEIKRT VAAPSVFIFP
PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
(Disulfide bridge: H22-H96, H127-L215, H140-H196, H219-H'219, H222-H'222, H254-H314, H360-H418, H'22-H'96, H'127-L'215, H'140-H'196, H'254-H'314, H'360-H'418, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  Type
Peptide
Efficacy
Myostatin inhibitor
  Type
Monoclonal antibody
Comment
Treatment of muscle wasting disorders
Target
MSTN [HSA:2660] [KO:K05497]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Transforming growth factors (RSTK-binding)
    MSTN
     D11235  Landogrozumab (USAN/INN)
Other DBs
CAS: 1391726-30-9
PubChem: 384585213
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system